Terms: = Germ cell tumor AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400 AND Treatment
848 results:
1. Principles in the Management of Glioblastoma.
Roda D; Veiga P; Melo JB; Carreira IM; Ribeiro IP
Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674436
[TBL] [Abstract] [Full Text] [Related]
2. Differences in Childhood Growth Parameters Between Patients With Somatic and Heritable Retinoblastoma.
Hicks RM; Ji X; Zou Y; Sultana S; Rashid R; Sherief ST; Cassoux N; Garcia Leon JL; Diaz Coronado RY; López AMZ; Ushakova TL; Polyakov VG; Roy SR; Ahmad A; Reddy MA; Sagoo MS; Al Harby L; Berry JL; Polski A; Astbury NJ; Bascaran C; Blum S; Bowman R; Burton MJ; Gomel N; Keren-Froim N; Madgar S; Zondervan M; Kaliki S; Fabian ID; Stacey AW
Invest Ophthalmol Vis Sci; 2024 Apr; 65(4):39. PubMed ID: 38662390
[TBL] [Abstract] [Full Text] [Related]
3. Recent progress in retinoblastoma: Pathogenesis, presentation, diagnosis and management.
Zhou M; Tang J; Fan J; Wen X; Shen J; Jia R; Chai P; Fan X
Asia Pac J Ophthalmol (Phila); 2024; 13(2):100058. PubMed ID: 38615905
[TBL] [Abstract] [Full Text] [Related]
4. Trauma plays an important role in acral melanoma: A retrospective study of 303 patients.
Huang R; Zhao M; Zhang G; Yang Y; Wang J; Zheng K; Li L; Su X; Zhao L; Wu Y; Zou Z
Cancer Med; 2024 Apr; 13(7):e7137. PubMed ID: 38545846
[TBL] [Abstract] [Full Text] [Related]
5. Strabismus management in retinoblastoma survivors.
Masoomian B; Shields CL; Esfahani HR; Khalili A; Ghassemi F; Rishi P; Akbari MR; Khorrami-Nejad M
BMC Ophthalmol; 2024 Mar; 24(1):114. PubMed ID: 38481156
[TBL] [Abstract] [Full Text] [Related]
6. Low expression of NR1D1 and NR2E3 is associated with advanced features of retinoblastoma.
Ding J; Sun J; Ma RQ; Zheng K; Han YN
Int Ophthalmol; 2024 Mar; 44(1):133. PubMed ID: 38480634
[TBL] [Abstract] [Full Text] [Related]
7. Regulation of cell Cycle Progression through RB Phosphorylation by Nilotinib and AT-9283 in Human Melanoma A375P cells.
Pham TM; Ahmed M; Lai TH; Bahar ME; Hwang JS; Maulidi RF; Ngo QN; Kim DR
Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474202
[TBL] [Abstract] [Full Text] [Related]
8. Glioblastoma Therapy: Past, Present and Future.
Obrador E; Moreno-Murciano P; Oriol-Caballo M; López-Blanch R; Pineda B; Gutiérrez-Arroyo JL; Loras A; Gonzalez-Bonet LG; Martinez-Cadenas C; Estrela JM; Marqués-Torrejón MÁ
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473776
[TBL] [Abstract] [Full Text] [Related]
9. Diagnostic Imaging for Retinoblastoma Cancer Staging: Guide for Providing Essential Insights for Ophthalmologists and Oncologists.
Pai V; Muthusami P; Ertl-Wagner B; Shroff MM; Parra-Fariñas C; Sainani K; Kletke S; Brundler MA; Mallipatna A
Radiographics; 2024 Apr; 44(4):e230125. PubMed ID: 38451848
[TBL] [Abstract] [Full Text] [Related]
10. Characteristics of patients with recurrent retinoblastoma: a survival analysis.
Li N; Wang YZ; Zhang Y; Zhang WL; Huang DS
BMC Cancer; 2024 Mar; 24(1):287. PubMed ID: 38438837
[TBL] [Abstract] [Full Text] [Related]
11. Management of Recurrence in Retinoblastoma Based on the Source of tumor cells.
Thaker SK; Shah PK; Das A; Maitra P
Middle East Afr J Ophthalmol; 2023; 30(1):24-30. PubMed ID: 38435107
[TBL] [Abstract] [Full Text] [Related]
12. METTL14-Mediated m6a Modification of CDKN2A Promotes the Development of Retinoblastoma by Inhibiting the p53 Pathway.
Chen J; Zeng B
Crit Rev Immunol; 2024; 44(3):89-98. PubMed ID: 38421707
[TBL] [Abstract] [Full Text] [Related]
13. FTO promotes the progression of retinoblastoma through YTHDF2-dependent N6-methyladenosine modification in E2F3.
Xie W; Shao Y; Bo Q; Li Z; Yu Q; Wang L; Wu G
Mol Carcinog; 2024 May; 63(5):926-937. PubMed ID: 38380957
[TBL] [Abstract] [Full Text] [Related]
14. Genetic and epigenetic features of neuroendocrine prostate cancer and their emerging applications.
Zhang X; Barnett E; Smith J; Wilkinson E; Subramaniam RM; Zarrabi A; Rodger EJ; Chatterjee A
Int Rev Cell Mol Biol; 2024; 383():41-66. PubMed ID: 38359970
[TBL] [Abstract] [Full Text] [Related]
15. Circulating tumor DNA Posttreatment Measurements and Clinical Correlates in Retinoblastoma.
Abramson DH; Robbins MA; Gobin YP; Dunkel IJ; Francis JH
JAMA Ophthalmol; 2024 Mar; 142(3):257-261. PubMed ID: 38300595
[TBL] [Abstract] [Full Text] [Related]
16. When the second comes first- rhabdomyosarcoma preceding heritable retinoblastoma- a case report.
Tripathy D; Moulin A; Bijon J; Gengler C; Beck-Popovic M; Munier FL; Stathopoulos C
BMC Ophthalmol; 2024 Jan; 24(1):47. PubMed ID: 38291358
[TBL] [Abstract] [Full Text] [Related]
17. Inhibition of Autophagy Aggravates
Tsai CH; Huang HC; Lin KJ; Liu JM; Chen GL; Yeh YH; Lu TL; Lin HW; Lu MT; Chu PC
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279345
[TBL] [Abstract] [Full Text] [Related]
18. Global retinoblastoma studies: A review.
Vempuluru VS; Maniar A; Kaliki S
Clin Exp Ophthalmol; 2024 Apr; 52(3):334-354. PubMed ID: 38263682
[TBL] [Abstract] [Full Text] [Related]
19. Targeted therapies in retinoblastoma: GD2-directed immunotherapy following autologous stem cell transplantation and evaluation of alternative target B7-H3.
Eichholz T; Heubach F; Arendt AM; Seitz C; Brecht IB; Ebinger M; Flaadt T; Süsskind D; Richter L; Hülsenbeck I; Zerweck L; Göricke S; Paulsen F; Dombrowski F; Flotho C; Schönberger S; Ketteler P; Schulte J; Lang P
Cancer Immunol Immunother; 2024 Jan; 73(1):19. PubMed ID: 38240863
[TBL] [Abstract] [Full Text] [Related]
20. treatment-related Neuroendocrine Prostate Carcinoma-Diagnostic and Molecular Correlates.
Gopalan A
Adv Anat Pathol; 2024 Mar; 31(2):70-79. PubMed ID: 38223983
[TBL] [Abstract] [Full Text] [Related]
[Next]
